More articles from Lung cancer

Exploiting the kynurenine pathway to combat platinum-resistant non-small cell lung cancer (NSCLC)
Medhi Wangpaichitr, Chunjing Wu, George Theodore, Sydney Spector, Dan Nguyen, Lynn Feun, Niramol Savaraj

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1712; DOI: 10.1183/13993003.congress-2023.PA1712
Clinical risk factors for checkpoint pneumonitis vs. other pneumonitis in lung cancer patients treated with checkpoint inhibitors
Lukas Wehlte, Lea Daisenberger, Julia Walter, Lucie Heinzerling, Thomas Pfluger, Amanda Tufman

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1711; DOI: 10.1183/13993003.congress-2023.PA1711
Relationship between age and chemotherapy regimen for elderly patients with advanced lung cancer
Ritsuya Shiiba, Yoshihito Kogure, Hiroto Murao, Yuki Takigawa, Atsushi Torii, Arisa Yamada, Yuka Shinohara, Hidemasa Niwa, Masahiro Sano, Chiyoe Kitagawa, Masahide Oki

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1697; DOI: 10.1183/13993003.congress-2023.PA1697
Extracellular vesicles derived from central nervous system suppresses antitumor immunity
Jiao‐li Wang, Man Luo, Li-Min Wang, Zhi-Jian Cai

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1703; DOI: 10.1183/13993003.congress-2023.PA1703
Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection
Kristina Krpina, Ena Tolić, Dora Darapi, Ana Hećimović, Dina Mihelčić Korte, Miroslav Samaržija, Lara Batičić

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1701; DOI: 10.1183/13993003.congress-2023.PA1701
Identification of predictive factors for early relapse in patients with unresectable stage Ⅲ NSCLC receiving consolidation durvalumab after concurrent chemoradiation therapy
Jung Hyun Nam, Chang Dong Yeo, Chan Kwon Park, Sung Kyoung Kim, Ju Sang Kim, Yong Hyun Kim, Jin Woo Kim, Seung Joon Kim, Sang Haak Lee, Hye Seon Kang

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1698; DOI: 10.1183/13993003.congress-2023.PA1698
Smoking status at time of diagnosis affects the efficacy of anti-PD-1/L1 therapy in patients with advanced non-small cell lung cancer
Kim Kyu Yean, Kim Jin Woo, Yeo Chang Dong

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1707; DOI: 10.1183/13993003.congress-2023.PA1707
Quantitative analysis of preoperative, intraoperative and postoperative circulating cell-free DNA in patients with resectable non-small cell lung cancer
Stylianos Gaitanakis, Anna Papadopoulou, Eleni Kokkotou, Timothy Sakellaridis, Periklis Tomos, Lamprini Stournara, Maria Mani, Eleutheria Ntalakou, Andriani Charpidou, Dimitra Grapsa

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1699; DOI: 10.1183/13993003.congress-2023.PA1699
Comparing the Effectiveness of Different Anti-angiogenetic Agents Combined with an EGFR-TKI in Metastatic Lung Adenocarcinoma
Chung-Wen Huang, Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, Inn-Wen Chong

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1714; DOI: 10.1183/13993003.congress-2023.PA1714
Prognostic implication of KRAS G12C mutation in a real-world KRAS mutated stage IV NSCLC cohort treated with immunotherapy in the Netherlands
Anneloes L. Noordhof, Esther M. Swart, Ronald A.M. Damhuis, Lizza E.L. Hendriks, Peter W.A. Kunst, Mieke J. Aarts, Wouter H. Van Geffen

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1705; DOI: 10.1183/13993003.congress-2023.PA1705

Main menu

User menu

Search

More articles from Lung cancer

Pages

Contact us